Scientific Advisory Board

Andre Terzic

Mayo Clinic, USA

Andre Terzic is Professor of Medicine and Pharmacology at Mayo Clinic, where he holds the Marriott Professorship in Cardiovascular Research and serves as Director, Marriott Heart Disease Research Program; Director, NIH "Cardiovasology" Program; Co-Director, Kogod Program on Aging; and is Associate Director for Research.

David Grainger

University of Utah, USA

Prof. David W. Grainger is a University Distinguished Professor and Department Chair and Professor of Bioengineering, and Professor of Pharmaceutics and Pharmaceutical Chemistry at the University of Utah, USA.

Janice Hogan

Partner – Hogan Lovells, USA

Joyce Wong

Boston University, USA

Professor Joyce Wong is Professor of Biomedical Engineering and Materials Science and Engineering at Boston University

Karen Hirschi

University of Virginia, USA

Katja Schenke-Layland

University of Tübingen, Germany

Professor Katja Schenke-Layland is Professor of Medical Technologies and Regenerative Medicine at the Eberhard Karls University Tübingen

Kevin E. Bennet

Mayo Clinic, USA

Kevin E. Bennet, Ph.D., M.B.A., serves as chair of the Division of Engineering and co-director of the Neural Engineering Laboratories at Mayo Clinic in Minnesota.

Maria Vicent

Centro de Investigación Príncipe Felipe, Spain

Professor MJ Vicent is Professor of Polymer Therapeutics at Centro de Investigación Príncipe Felipe, Spain

Michael Sefton

University of Toronto, Canada

Professor Michael Sefton is regarded as a pioneer in tissue engineering and a leader in biomaterials, biomedical engineering and regenerative medicine.

Scott Hollister

Georgia Institute of Technology, USA

Scott Hollister is a Professor of Biomedical Engineering at the Georgia Institute of Technology.

Suzie Pun

University of Washington, USA

Professor Suzie Pun is Washington Research Professor of Bioengineering at the University of Washington.

Vincent Ling

Takeda Pharmaceuticals

Dr. Ling currently serves as Senior Director within Search and Evaluation, Business Development at Takeda, after directorship roles in external innovation and pharmaceutical sciences.